Jaime Bosch

Has grant

Emeritus Professor of Medicine

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jaime Bosch is an Emeritus Professor of Medicine at the University of Barcelona, Spain. His research focuses on liver diseases, particularly in the areas of cirrhosis, portal hypertension, and metabolic liver conditions. He has recently contributed to significant findings in the assessment of intravascular volume in cirrhosis patients, the use of statins for liver disease management, and strategies for preventing the progression of cirrhosis.

Recent Grants

Grant: Close

CLEVER

Open Date: 2014-01-01

Close Date:

Grant: Close

Prevention of portal hypertensive complications

Open Date:

Close Date:

Articles (22)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (6)

Agustin Albillos

Professor of Medicine

Universidad de Alcalá

SPAIN

View details

Gerard Sergi Angeles-Fite

University Hospital of Bern

SWITZERLAND

View details

Ferran Torres

Universitat Autònoma de Barcelona (UAB)

SPAIN

View details

MOJGAN MASOODI

Associate Professor

Inselspital Universitätsspital Bern

SWITZERLAND

View details

Jordi Gracia-Sancho

Research Professor

Institut d'Investigacions Biomèdiques August Pi i Sunyer

SPAIN

View details

Thomas Reiberger

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jaime Bosch

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (22)

Point-of-care ultrasound of the inferior vena cava for intravascular volume assessment during intravenous albumin infusion in patients with cirrhosis

Preventing the progression of cirrhosis to decompensation and death

Endoscopic diagnosis and treatment for portal hypertension: not yet ready for clinical practice!

Statins for MAFLD/MASH: another brick in the wall while waiting for final answers

Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: a post-hoc analysis of the PREDESCI trial

Metabolic phenotyping of patients with advanced chronic liver disease for better characterization of cirrhosis regression

AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis

Combination of Model for End-Stage Liver Disease (MELD) and Sarcopenia predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS)

Hepatic Venous Pressure Gradient: Measurement and Pitfalls

Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding

Quantifying the benefit of non-selective beta-blockers in the prevention of hepatic decompensation:

Reply to: “Carvedilol in patients with compensated cirrhosis: The ongoing benefits of definitive randomised trials over meta-analysis in patients with small varices”

Carvedilol as Best β-Blocker for Secondary Prophylaxis of Variceal Bleeding: Are We There, or Not Yet?

Mechanobiology of portal hypertension

Emerging Therapeutic Targets for Portal Hypertension

Letter: PCSK9 inhibitor for liver transplant patients during the post‐statin era? Authors' reply

Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data

Pre-emptive TIPS in high-risk acute variceal bleeding.

Reply to: ‘Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma’

Baveno VII – Renewing consensus in portal hypertension

Autoimmune hepatitis triggered by SARS-CoV-2 vaccination

Annals for Hospitalists Inpatient Notes - Clinical Pearls—Hepatorenal Syndrome

Collaborators (6)

Agustin Albillos

Gerard Sergi Angeles-Fite

Ferran Torres

MOJGAN MASOODI

Jordi Gracia-Sancho

Thomas Reiberger

Make your next move.